Citigroup’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,210
| Closed | -$27.3K | – | 4919 |
|
|
2025
Q1 | $27.3K | Buy |
10,210
+10,209
| +1,020,900% | +$27.3K | ﹤0.01% | 4256 |
|
|
2024
Q4 | $4 | Hold |
1
| – | – | ﹤0.01% | 4917 |
|
|
2024
Q3 | $16 | Hold |
1
| – | – | ﹤0.01% | 4768 |
|
|
2024
Q2 | $27 | Hold |
1
| – | – | ﹤0.01% | 4706 |
|
|
2024
Q1 | $36 | Hold |
1
| – | – | ﹤0.01% | 4732 |
|
|
2023
Q4 | $27 | Hold |
1
| – | – | ﹤0.01% | 4789 |
|
|
2023
Q3 | $34 | Hold |
1
| – | – | ﹤0.01% | 4785 |
|
|
2023
Q2 | $33 | Hold |
1
| – | – | ﹤0.01% | 4726 |
|
|
2023
Q1 | $53 | Hold |
1
| – | – | ﹤0.01% | 4587 |
|
|
2022
Q4 | $48 | Sell |
1
-2
| -67% | -$96 | ﹤0.01% | 4859 |
|
|
2022
Q3 | $0 | Sell |
3
-2
| -40% | – | ﹤0.01% | 5080 |
|
|
2022
Q2 | $1K | Sell |
5
-3
| -38% | -$600 | ﹤0.01% | 5202 |
|
|
2022
Q1 | $5K | Sell |
8
-23
| -74% | -$14.4K | ﹤0.01% | 4990 |
|
|
2021
Q4 | $39K | Buy |
31
+19
| +158% | +$23.9K | ﹤0.01% | 4418 |
|
|
2021
Q3 | $35K | Buy |
12
+7
| +140% | +$20.4K | ﹤0.01% | 4193 |
|
|
2021
Q2 | $26K | Buy |
+5
| New | +$26K | ﹤0.01% | 4477 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5510 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 5484 |
|
|
2014
Q3 | – | Hold |
0
| – | -$1K | – | 5448 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 5260 |
|